Drug profile · INN
gepotidacin mesylate
BLUJEPA
gepotidacin mesylate (BLUJEPA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Drug details — gepotidacin mesylate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
gepotidacin mesylate (BLUJEPA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is gepotidacin mesylate?
gepotidacin mesylate (BLUJEPA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for gepotidacin mesylate?
BLUJEPA is a marketed brand name for gepotidacin mesylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of gepotidacin mesylate?
gepotidacin mesylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.